Skip to main content
. 2021 Aug 20;10(16):3701. doi: 10.3390/jcm10163701

Table 1.

Baseline characteristics of Takotsubo Syndrome Patients with or without Malignancy.

Characteristics
All Malignancy No Malignancy p Value
Number of admissions 61,583 7542 (12.2) * 54,041 (87.8)
Patient characteristics
Age, mean (SE), y 66.7 (0.1) 70.6 (0.2) 66.1 (0.1) <0.001 †
Age ≥ 70 yrs 27,109 (44.0) 4328 (57.4) 22,781 (42.2) <0.001 ‡
Female 54,708 (88.8) 6499 (86.2) 48,209 (89.2) <0.001
Smoking history 21,834 (35.5) 2864 (38.0) 18,970 (35.1) 0.005
Hypertension 40,597 (65.9) 4900 (65.0) 35,697 (66.1) 0.350
Diabetes mellitus 11,701 (19.0) 1405 (18.6) 10,296 (19.1) 0.620
Dyslipidemia 26,830 (43.6) 3102 (41.1) 23,728 (43.9) 0.014
Known coronary artery disease 25,910 (42.1) 3495 (46.3) 22,415 (41.5) <0.001
Previous myocardial infarction 3833 (6.2) 444 (5.9) 3389 (6.3) 0.463
Previous PCI 2988 (4.9) 341 (4.5) 2647 (4.9) 0.458
Previous CABG 933 (1.5) 91 (1.2) 842 (1.6) 0.177
Family history of coronary artery disease 5249 (8.5) 448 (5.9) 4801 (8.9) <0.001
Congestive heart failure 18,531 (30.1) 2552 (33.8) 15,979 (29.6) <0.001
Peripheral vascular disease 4544 (7.4) 608 (8.1) 3936 (7.3) 0.156
Chronic pulmonary disease 17,732 (28.8) 2396 (31.8) 15,336 (28.4) <0.001
Chronic kidney disease 4862 (7.9) 670 (8.9) 4192 (7.8) 0.075
Liver disease 1238 (2.0) 116 (1.5) 1122 (2.1) 0.070
Anemia 9425 (15.3) 1456 (19.3) 7969 (14.7) <0.001
Atrial fibrillation 8744 (14.2) 1338 (17.7) 7406 (13.7) <0.001
Coagulopathy 2699 (4.4) 485 (6.4) 2214 (4.1) <0.001
Collagen vascular disease 2683 (4.4) 282 (3.7) 2401 (4.4) 0.117
Fluid/electrolyte disorders 18,576 (30.2) 2658 (35.2) 15,918 (29.5) <0.001
Obesity 6554 (10.6) 537 (7.1) 6017 (11.1) <0.001
Other neurological disorders 5196 (8.4) 599 (7.9) 4597 (8.5) 0.429
Pulmonary circulatory disease 1243 (2.0) 252 (3.3) 991 (1.8) <0.001
Valvular heart disease 1592 (2.6) 296 (3.9) 1296 (2.4) <0.001
Median household income <0.001
First quartile 16,024 (26.4) 1739 (23.3) 14,285 (26.8)
Second quartile 15,865 (26.1) 1957 (26.2) 13,908 (26.1)
Third quartile 14,949 (24.6) 1816 (24.3) 13,133 (24.7)
Fourth quartile 13,849 (22.8) 1953 (26.2) 11,896 (22.4)
Primary payer <0.001
Medicare 37,851 (61.5) 5462 (72.4) 32,389 (59.9)
Medicaid 4028 (6.5) 389 (5.2) 3639 (6.7)
Private including HMO 15,388 (25.0) 1435 (19.0) 13,953 (25.8)
Self-pay/no charge/other 4315 (7.0) 256 (3.4) 4059 (7.5)
Hospital characteristics
Hospital teaching status <0.001
Teaching 35,931 (58.3) 4799 (63.6) 31,132 (57.6)
Nonteaching 25,652 (41.7) 2743 (36.4) 22,909 (42.4)
Hospital location 0.149
Rural 212 (0.3) 13 (0.2) 199 (0.4)
Urban 61,371 (99.7) 7529 (99.8) 53,842 (99.6)
Hospital bed size 0.240
Small 4612 (7.5) 503 (6.7) 4109 (7.6)
Medium 13,769 (22.4) 1643 (21.8) 12,126 (22.4)
Large 43,203 (70.2) 5396 (71.5) 37,807 (70.0)
Length of stay > 5 days 18,588 (30.2 3134 (41.6) 15,454(28.6) <0.001
Disposition <0.001
Home 44,092 (71.6) 4552 (60.4) 39,540 (73.2)
Facility § 15,710 (25.5) 2632 (34.9) 13,078 (24.2)
AMA/unknown 1777 (2.9) 358 (4.7) 1419 (2.6)
Mood disorders 11,502 (18.7) 11,354 (18.0) 10,148 (18.8) 0.378
Substance abuse 2676 (4.3) 165 (2.2) 2511 (4.6) <0.001
Delirium/Dementia 2667 (4.3) 365 (4.8) 2302 (4.3) 0.213
Personality disorder 103 (0.2) 0 (0) 103 (0.2) 0.061
Acute decompensated heart failure 10,571 (17.2) 1472 (19.5) 9099 (16.8) 0.003
Cardiogenic shock 3564 (5.8) 582 (7.7) 2982 (5.5) <0.001
Cardiac arrest 1663 (2.7) 221 (2.9) 1442 (2.7) 0.544
Postop stroke (complication) 792 (1.3) 103 (1.4) 689 (1.3) 0.704
Arrhythmia 16,868 (27.4) 2394 (31.7) 14,474 (26.8) <0.001

Abbreviations: SE, standard error; PCI, percutaneous coronary intervention; CABG, coronary artery bypass grafting; HMO, health maintenance organization; AMA, against medical advice. * Values are presented as number (percentage) of patients unless otherwise indicated. † Survey-specific linear regression was performed. ‡ Rao-Scott χ2 test was used for all statistical tests unless stated otherwise. § Facility includes skilled nursing facility, intermediate care facility, and inpatient rehabilitation facility.